E-Books durchsuchen
Label‐Free Technologies for Drug Discovery [2011]
- 1
-
The Revolution of Real‐Time, Label‐Free Biosensor Applications
- 27
-
Design and Implementation of Vertically Emitting Distributed Feedback Lasers for Biological Sensing
- 41
-
SPR Screening of Chemical Microarrays for Fragment‐Based Discovery
- 57
-
The CellKey® System: A Label‐Free Cell‐Based Assay Platform for Early Drug Discovery Applications
- 71
-
Dynamic and Label‐Free Cell‐Based Assays Using the xCELLigence System
- 83
-
Selecting the Best HTS Hits to Move Forward: ITC Ligand Binding Characterization Provides Guidance
- 101
-
Incorporating Transmitted Light Modalities into High‐Content Analysis Assays
- 111
-
Nonradioactive Rubidium Efflux Assay Technology for Screening of Ion Channels
- 125
-
Expanding the Scope of HTMS Methods
- 141
-
A Novel Multiplex SPR Array for Rapid Screening and Affinity Determination of Monoclonal Antibodies: The ProteOn XPR36 Label Free System: Kinetic Screening of Monoclonal Antibodies
- 155
-
Biophysics/Label‐Free Assays in Hit Discovery and Verification
- 171
-
Harnessing Optical Label‐Free on Microtiter Plates for Lead Finding: From Binding to Phenotypes
- 189
-
Use of Label‐Free Detection Technologies in the Hit‐to‐Lead Process: Surface Optical Detection of Cellular Processes
- 205
-
Cellular Screening for 7TM Receptors Using Label‐Free Detection
- 223
-
Novartis Evaluation of the ForteBio Octet RED: A Versatile Instrument for Direct Binding Experiments
- 241
-
The Pyramid™ Approach to Fragment‐Based Biophysical Screening
- 255
-
Characterisation of Antibodies Against the Active Conformation of G<sub>αi1</sub> Using the SRU‐BIND® Label‐Free Detection System
- 269
-
SPR‐Based Direct Binding Assays in Drug Discovery
- 283
-
Kinetic Binding Mechanisms: Their Contribution to an Optimal Therapeutic Index
- 303
-
ITC: More Than Just Binding Affinities
- 313
-
Index
- i
-
Front Matter